Presentation TCT 2017 Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding Presenter: Michelle O'Donoghue November 01, 2017 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2017 CAD Pharma Up Next Presentation TCT 2017 When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy? Presenter: Roxana Mehran November 01, 2017 More slides + Presentation TCT 2017 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI Presenter: Christopher B. Granger November 01, 2017 Presentation TCT 2017 When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies Presenter: Michael D. Ezekowitz November 01, 2017 We Recommend
Presentation TCT 2017 When and Which Antiplatelet Agent Should Be Dropped When Using Oral Anticoagulant Therapy? Presenter: Roxana Mehran November 01, 2017
Presentation TCT 2017 Acute Anticoagulation Management and Bleeding Avoidance Strategies in the Chronic Atrial Fibrillation Patient Who Requires PCI Presenter: Christopher B. Granger November 01, 2017
Presentation TCT 2017 When Bleeding Occurs on Warfarin or NOAC: Reversal Strategies Presenter: Michael D. Ezekowitz November 01, 2017